Association between patient-reported outcomes (PROs) and changes in prostate-specific antigen (PSA) in patients (pts) with advanced prostate cancer treated with apalutamide (APA) in the SPARTAN and TITAN studies. Meeting Abstract

cited authors

  • Small, Eric Jay; Chi, Kim N.; Chowdhury, Simon; Bevans, Katherine B.; Bhaumik, Amitabha; Saad, Fred; Chung, Byung; Karsh, Lawrence Ivan; Oudard, Stephane; De Porre, Peter; Brookman-May, Sabine D.; McCarthy, Sharon Anne; Mundle, Suneel; Uemura, Hirotsugu; Smith, Matthew Raymond; Agarwal, Neeraj; SPARTAN TITAN investigators

Publication Date

  • February 20, 2022

webpage

published in

category

volume

  • 40

issue

  • 6